🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare brolucizumab (RTH258) ophthalmic so...
Status
Completed
Location
Contact Alcon Call Center for Trial Locations
Start Date
2014-12-08
Trial ID
NCT02307682
Treatments Being Tested
Regeneron Pharmaceuticals developed a single-dose pre-filled syringe (PFS) ...
Status
Completed
Location
Retina Consultants of Texas
Start Date
2024-04-15
Trial ID
NCT05989126
Treatments Being Tested
This will be a randomized, comparative, parallel, clinical study to assess ...
Status
Recruiting
Location
CBCC Global Research Site:005
Start Date
2023-12-22
Trial ID
NCT06132035
Treatments Being Tested
This study is designed to evaluate the safety and efficacy of every 2 week ...
Status
Unknown
Location
Tennessee Retina
Start Date
2018-04
Trial ID
NCT03468296
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of ESBA1008...
Status
Completed
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT01796964
Treatments Being Tested
This study was designed to characterize the effect of aflibercept in partic...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2006-07
Trial ID
NCT00327444
The currently widely established and preferred protocol for the treatment o...
Status
Active Not Recruiting
Location
Berner Augenklinik
Start Date
2022-05-09
Trial ID
NCT04932980
Treatments Being Tested
The primary objective of this study is to is to assess the ability of retin...
Status
Completed
Location
Retina Consultants of Texas - Austin Retina
Start Date
2023-01-23
Trial ID
NCT05704725
Treatments Being Tested
Multicenter randomized trials have demonstrated the safety and efficacy of ...
Status
Unknown
Location
Maisonneuve Rosemont Hospital
Start Date
2016-11
Trial ID
NCT02924987
Treatments Being Tested
The primary objective of the study is to compare the efficacy of intravitre...
Status
Completed
Location
Regeneron Investigational Site
Start Date
2016-03-31
Trial ID
NCT02713204
Treatments Being Tested